Do molecular diagnostics add to clinical characteristics in selecting patients for gefitinib treatment?
Janjigian
Yelena Y
YY
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Miller
Vincent A
VA